Title
Category
Credits
Event date
Cost
A Nurse’s Guide to SGLT2i Therapy - Kristi Kelley
  • Brookwood Baptist Health CE
  • 1.20 ABN
  • 1.00 ABSWE
12/04/2025
$0.00
Nurses play a vital role in managing and educating patients with type 2 diabetes, heart failure, and chronic kidney disease. These are all conditions for which sodium–glucose co-transporter 2 (SGLT2) inhibitors have become essential therapies. As this drug class continues to be recommended in major guidelines, frontline nursing staff are frequently responsible for monitoring patients on these agents, recognizing early signs of adverse effects, counseling on proper use, and helping patients navigate issues related to cost and insurance coverage. 
Recent Updates for the Management of Community-Acquired Pneumonia
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
12/04/2025
$0.00
Community-acquired pneumonia (CAP) is one of the most common infectious diseases encountered in both the inpatient and outpatient settings.  Additionally, it is a significant cause of both morbidity and mortality.  Clinical practice guidelines for the treatment of CAP were published in 2019, and in 2025, a focused update to these guidelines was released, which focused on four primary questions.  Healthcare providers must be familiar with both the 2019 and 2025 guidelines to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship
ENCORE Recent Updates for the Management of Community-Acquired Pneumonia
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
12/09/2025
$0.00
Community-acquired pneumonia (CAP) is one of the most common infectious diseases encountered in both the inpatient and outpatient settings.  Additionally, it is a significant cause of both morbidity and mortality.  Clinical practice guidelines for the treatment of CAP were published in 2019, and in 2025, a focused update to these guidelines was released, which focused on four primary questions.  Healthcare providers must be familiar with both the 2019 and 2025 guidelines to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship